Citius Oncology annual current ratio
2021
2022
2022
2023
2023
2024
2025
Citius Oncology Current Ratio Growth & History (CTOR)
Citius Oncology's current ratio was 0.56 for fiscal 2025.
View full Citius Oncology company overviewCitius Oncology annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 0.56 | 0.22 | +65.91% |
| 2024 | 2024-09-30 | 0.34 | −0.03 | −8.73% |
| 2023 · Dec 31 | 2023-12-31 | 0.03 | −11.82 | −99.76% |
| 2023 · Sep 30 | 2023-09-30 | 0.37 | −0.09 | −20.13% |
| 2022 | 2022-12-31 | 11.85 | 10.93 | +1180.09% |
| 2022 | 2022-09-30 | 0.46 | — | — |
| 2021 | 2021-12-31 | 0.93 | — | — |
Citius Oncology quarterly current ratio
Q4.21
Q4.22
Q1.23
Q2.23
Q4.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 0.73 | 0.38 | +110.26% |
| Q2 2026 | 2026-03-31 | 0.50 | 0.14 | +37.95% |
| Q1 2026 | 2025-12-31 | 0.83 | 0.44 | +111.09% |
| Q4 2025 | 2025-09-30 | 0.56 | 0.22 | +65.91% |
| Q3 2025 | 2025-06-30 | 0.35 | 0.33 | +2497.14% |
| Q2 2025 | 2025-03-31 | 0.36 | 0.33 | +983.10% |
| Q1 2025 | 2024-12-31 | 0.39 | 0.37 | +1283.48% |
| Q4 2024 | 2024-09-30 | 0.34 | −0.03 | −8.73% |
| Q2 2024 | 2024-06-30 | 0.01 | −0.98 | −98.66% |
| Q1 2024 | 2024-03-31 | 0.03 | −5.10 | −99.35% |
| Q4 2023 · Dec 31 | 2023-12-31 | 0.03 | −11.82 | −99.76% |
| Q4 2023 · Sep 30 | 2023-09-30 | 0.37 | — | — |
| Q2 2023 | 2023-06-30 | 1.00 | — | — |
| Q1 2023 | 2023-03-31 | 5.14 | — | — |
| Q4 2022 | 2022-12-31 | 11.85 | 10.93 | +1180.09% |
| Q4 2021 | 2021-12-31 | 0.93 | — | — |
Citius Oncology current ratio trends
Between the periods ended 2021-12-31 and 2025-09-30, Citius Oncology's current ratio decreased from 0.93 to 0.56, a change of −0.37. The latest reported quarter, Q3 2026, shows 0.73.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Oncology source filings ↗